Investigator
John Francis Kelly
MASSACHUSETTS GENERAL HOSPITAL · funded by NIAAA
- Companies
- 1
- Grants
- 2
- Non-dilutive funding
- $1.5M
- First award
- Jun 20, 2023
Resolved onto their grants.
Federal awards on file.
Summed across those awards.
On this record.
Companies from this work
Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.
- NORTHERN CALIFORNIA INSTITUTE/RES/EDU100momentum
OncologyFiled/Approved
Grant record
Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.
- R01
Integrated Treatment for Enhancing Growth in Recovery during Adolescence (InTEGRA)
$740kJun 20, 2023NIAAAMASSACHUSETTS GENERAL HOSPITALNIH RePORTER · 11112523 (opens the source filing in a new tab)
- R01
Integrated Treatment for Enhancing Growth in Recovery during Adolescence (InTEGRA)
$734kJun 20, 2023NIAAAMASSACHUSETTS GENERAL HOSPITALNIH RePORTER · 11380650 (opens the source filing in a new tab)
This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources